ZNF84 Inhibitors
Chemical inhibitors of ZNF84 utilize various mechanisms to impede the protein's function. Chelerythrine and Bisindolylmaleimide I target the protein indirectly by inhibiting protein kinase C (PKC), which is vital for the phosphorylation processes that may activate ZNF84 or modulate its DNA-binding activity. Similarly, PD98059 and U0126 are both inhibitors of MEK, an upstream kinase in the MAPK/ERK pathway, a pathway that can regulate the activity of ZNF84 through phosphorylation. By inhibiting MEK, these chemicals prevent the activation of ERK, which may be necessary for ZNF84 activity. LY294002 and Wortmannin exert their effects by inhibiting PI3K, a kinase that participates in the PI3K/Akt signaling pathway. The inhibition of PI3K results in reduced phosphorylation of downstream targets, which can be crucial for the activation and function of ZNF84.
Further, SB203580 and SP600125 specifically inhibit p38 MAP Kinase and JNK, respectively, both of which are key components of the MAPK signaling pathways. The inhibition of these kinases disrupts their respective pathways and the phosphorylation of substrates that could be essential for ZNF84's regulation and function. On the epigenetic front, Trichostatin A and C646 affect the structure and accessibility of chromatin. Trichostatin A, a histone deacetylase inhibitor, changes the chromatin landscape, potentially affecting ZNF84's ability to bind DNA. C646, by inhibiting the histone acetyltransferase p300, can prevent the acetylation that may be necessary for ZNF84's interaction with chromatin. Lastly, RG108 and 5-Azacytidine alter the DNA methylation status. RG108 inhibits DNA methyltransferases, potentially disrupting ZNF84's interaction with methylated DNA, while 5-Azacytidine incorporates into DNA and RNA, affecting methylation patterns and possibly influencing ZNF84's DNA-binding affinity. Each of these chemicals, through their specific target interactions, can lead to the functional inhibition of ZNF84 by modulating the necessary post-translational modifications or the chromatin context in which ZNF84 operates.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is known to inhibit protein kinase C (PKC). ZNF84, as a zinc finger protein, may require PKC-mediated phosphorylation for its DNA-binding activity, thus chelerythrine inhibits ZNF84 by inhibiting PKC which is necessary for ZNF84's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 acts as an inhibitor of MEK, which in turn is part of the MAPK/ERK pathway. The MAPK/ERK pathway may regulate the activity of ZNF84, and inhibition by PD98059 would prevent such regulatory phosphorylations, leading to functional inhibition of ZNF84. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K/Akt signaling can be involved in the functional regulation of transcription factors. By inhibiting PI3K, LY294002 could lead to decreased phosphorylation and activation of downstream targets necessary for ZNF84 function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of MEK1/2, key enzymes in the MAPK/ERK pathway which may be involved in the phosphorylation and regulation of ZNF84. Inhibition by U0126 would prevent activation of ZNF84 through this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAP Kinase, which is involved in the stress-activated MAPK pathway. p38 MAPK may be implicated in the regulation of ZNF84's activity or stability, and inhibition by SB203580 would disrupt ZNF84's functional role. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which is part of the MAPK signaling pathways. JNK may phosphorylate substrates that interact with or regulate ZNF84, and inhibiting JNK with SP600125 would impede these regulatory interactions, thereby inhibiting ZNF84 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K. By inhibiting PI3K, it could disrupt downstream signaling that may be critical for ZNF84's phosphorylation state and function, leading to its functional inhibition. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor. While it primarily affects chromatin structure and gene expression, the resulting changes in chromatin could inhibit the DNA binding capacity of ZNF84, leading to functional inhibition of its regulatory activities. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor. Though not directly inhibiting ZNF84, it can alter the methylation status of DNA, potentially disrupting the interaction of ZNF84 with its methylated DNA targets and inhibiting its function. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
C646 is a competitive inhibitor of the histone acetyltransferase p300. By inhibiting p300, it might prevent the acetylation of histones necessary for ZNF84 to access and bind DNA, thus functionally inhibiting ZNF84. | ||||||